BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 19859859)

  • 1. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital mammography screening: average glandular dose and first performance parameters.
    Weigel S; Girnus R; Czwoydzinski J; Decker T; Spital S; Heindel W
    Rofo; 2007 Sep; 179(9):892-5. PubMed ID: 17705112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany.
    Schott G; Reichel M; Junkermann H; Becker N
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):29-35. PubMed ID: 17602243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.
    Hofvind S; Lee CI; Elmore JG
    Breast Cancer Res Treat; 2012 Aug; 135(1):291-9. PubMed ID: 22833199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
    Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
    Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
    Weigel S; Hense HW; Heidrich J; Berkemeyer S; Heindel W; Heidinger O
    Radiology; 2016 Mar; 278(3):707-13. PubMed ID: 26505802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of organised mammography screening on stage-specific incidence in Norway: population study.
    Lousdal ML; Kristiansen IS; Møller B; Støvring H
    Br J Cancer; 2016 Mar; 114(5):590-6. PubMed ID: 26835975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
    Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
    Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.
    van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ;
    Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
    Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
    Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathological characteristics in screening versus clinically-detected breast cancer].
    Paziault M; Terrade FX; Fermeaux V; Pascal B; Darreye G; Dussartre C; Gilquin M; Labrousse F; Tubiana-Mathieu N
    Bull Cancer; 2006 Jul; 93(7):731-6. PubMed ID: 16873082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening.
    Weigel S; Heindel W; Heidrich J; Heidinger O; Hense HW
    Rofo; 2016 Jan; 188(1):33-7. PubMed ID: 26485700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer screening: have there been any changes during the last decade? A study in a Spanish unit.
    Martínez-Ramos D; Escrig-Sos J; García-Redón T; Fortea-Sanchis C; Alcalde-Sánchez M; Salvador-Sanchis JL
    Cir Cir; 2011; 79(5):402-8. PubMed ID: 22385759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.